Investors

To download our documents

Events

All events
26/01/2023

Degroof Petercam Healthcare Conference

26 January 2023

Read more
24/01/2023

Invest Securities BioMed Forum

January 24, 2023

Read more
09/01/2023

J.P. Morgan Healthcare Conference

9 - 12 January 2023

Read more

To receive OSE Immunotherapeutics’ latest news

Live stock price

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

Share price

ISIN

FR0012127173

Ticker

OSE

Type of listing

Continuous

Number of outstanding shares

18,285,038 shares as of 31 December 2021

Eligibility

Eligible to Long-Only Deferred Settlement Service

Financial calendar

This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).

30 March 2022

Annual financial results 2021

23 June 2022

General shareholders' meeting

22 September 2022

Half-year results 2022

Analysts

Read more
Degroof Petercam
David Seynnaeve
Invest Securities
Jamila El Bougrini
Edison
Jonas Peciulis

Analyst reports

Read more
19/10/2021 Bryan, Garnier & Co
15/10/2021 Maxim Group
02/09/2021 Maxim Group

Regulated information

Read more

General shareholders' meetings

Read more
23/06/2022

General Shareholders' Meeting 2022

All the documents below are in French (except "Summary of the resolutions" and "Voting form"

Results of each resolution of the Combined General Shareholders' Meeting

Financial information and publications

Read more
2022 First-half 2022 financial report
2022 Statutory Auditors' report on the condensated half-year financial statements (in French)
2021 2021 Universal registration document